Creator: Help Dementia Editorial Team
Published: 2026-04-04T08:02:21

Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.

Dementia prevention sits at the center of this dementia and brain health question.

While there isn’t a single clinical trial recruiting exactly 25,000 participants across 8 countries, the world’s largest coordinated dementia prevention effort—the World-Wide FINGERS Network (WW-FINGERS)—operates across more than 70 countries and includes multiple concurrent trials testing multidomain lifestyle interventions to prevent cognitive decline. The original FINGER trial in Finland made headlines by being the first to prove that lifestyle interventions could actually slow cognitive decline, showing a 25% greater improvement in the intervention group compared to controls. This article explores the global dementia prevention research landscape, from the groundbreaking Finnish trial that started it all to the international network now coordinating prevention studies across continents and recruiting thousands of participants to test whether exercise, diet, cognitive training, and vascular risk management can help prevent dementia.

What Is the World-Wide FINGERS Network and Why Does It Matter?
The Original FINGER Trial—The Study That Changed Everything
Global Trials and International Adaptation
The Multidomain Approach—Four Pillars of Prevention
Recruitment Challenges Across Diverse Populations
What Participating in a Dementia Prevention Trial Actually Involves
What the Future Holds for Dementia Prevention Research
Conclusion

What Is the World-Wide FINGERS Network and Why Does It Matter?

The World-Wide FINGERS Network was launched in 2017 by Professor Miia Kivipelto and operates as a coordinated global initiative rather than a single trial. As of June 2023, the network reported 13 completed trials, 15 ongoing trials, and several more in the planning phase—all built on the same core principle tested by the original Finnish study. This distributed model allows different countries and research centers to adapt the FINGER protocol (multidomain lifestyle intervention) to their own populations while maintaining scientific consistency across sites.

The network’s reach spans all continents, making it truly the largest coordinated effort in dementia prevention research. The reason this matters for patients and families is simple: if lifestyle interventions work to prevent cognitive decline, they’re far more accessible and affordable than waiting for pharmaceutical breakthroughs. The original FINGER trial suggested they do work, which is why it generated such interest among researchers worldwide. However, the results need to be tested across different populations, age groups, and healthcare systems to determine whether the benefits hold in real-world conditions.

What Is the World-Wide FINGERS Network and Why Does It Matter?

The Original FINGER Trial—The Study That Changed Everything

Before the FINGER trial, the prevailing assumption was that cognitive decline was inevitable with age and that once the brain started declining, little could be done to slow it. The Finnish FINGER study, conducted between 2009 and 2011, enrolled participants aged 60-77 with normal cognition but at risk for cognitive decline due to age, genetics, or vascular risk factors. This was crucial—the study targeted people before they developed dementia, not people who already had it.

The intervention group received 24 months of coordinated support in four areas: an exercise program (aerobic and strength training), nutritional counseling emphasizing a healthy diet, cognitive training through computerized exercises and mental stimulation, and regular monitoring and management of vascular risk factors like blood pressure and cholesterol. The control group received only general health advice. The results, published in The Lancet in 2015, showed that the intervention group experienced 25% greater improvement in cognitive function compared to the control group—a meaningful difference that demonstrated lifestyle changes could actually change the trajectory of brain aging. However, this was still a study in Finland with relatively small numbers, so questions remained about whether the same approach would work in other countries and populations.

Global Trials and International Adaptation

The success of the Finnish FINGER trial prompted researchers worldwide to launch their own studies using the same multidomain framework. The U.S. POINTER trial, for example, has enrolled over 2,100 participants and tests the FINGER approach in American adults aged 55 and older with subjective cognitive decline or mild cognitive impairment. PREVENTABLE focuses on whether statins might support dementia prevention in combination with lifestyle changes.

PrevenTRON is another multi-center prevention trial exploring variations of the intervention. Each of these trials allows researchers to answer region-specific questions: Does the intervention work for Americans? For people in low-income settings? For those with different baseline health conditions? The international expansion reveals an important reality: dementia prevention research isn’t a one-size-fits-all endeavor. A diet that works in Finland might need adjustment for a population with different food availability and cultural preferences. An exercise program developed for Scandinavian healthcare systems needs modification for countries with different clinic infrastructure. By spreading the research across 70+ countries, the WW-FINGERS network builds knowledge about these variations while accumulating the overall evidence base.

Global Trials and International Adaptation

The Multidomain Approach—Four Pillars of Prevention

The FINGER protocol rests on four evidence-based components, though research teams worldwide continue to refine which elements matter most. The exercise component typically includes at least 30 minutes of moderate-intensity aerobic activity most days of the week, combined with resistance training. The nutritional component emphasizes Mediterranean-style eating patterns, with attention to antioxidants, omega-3 fatty acids, and limiting processed foods and excess salt. Cognitive training involves structured mental exercises, often delivered through computerized programs but also including activities like learning a language or playing music.

Finally, vascular risk management involves monitoring and treating blood pressure, cholesterol, blood sugar, and other cardiovascular risk factors—many of which also increase dementia risk. However, there’s an important caveat: simply doing all four components isn’t necessarily better than doing some of them well. One trial might focus heavily on exercise because obesity rates in that region are high, while another emphasizes cognitive engagement in a population with existing cardiovascular disease. The flexibility allows researchers to understand which elements deliver the most benefit for different groups, but it also means participants in different trials are following somewhat different protocols. This is valuable for science but complicates the question “what should *I* do?”—the answer varies by context.

Recruitment Challenges Across Diverse Populations

Recruiting 25,000 or more participants across multiple countries presents significant logistical and cultural challenges. Different countries have different attitudes toward clinical trials, different healthcare systems for screening participants, and different populations willing to commit 12-24 months to intensive lifestyle interventions. Recruiting in Finland is different from recruiting in Nigeria, India, or Brazil—and all of these experiences matter for understanding who benefits from dementia prevention.

Some trials have struggled to enroll participants because the intervention requires genuine behavior change, not just taking a pill. Others have faced difficulties reaching lower-income populations, who often carry higher dementia risk but have fewer resources to participate in research. A critical limitation to understand: most dementia prevention trials still recruit predominantly educated, relatively affluent, healthy participants—exactly the group least likely to develop dementia. This means that while the FINGER protocol has proven effective in controlled research settings, it’s unclear whether it works equally well in underserved populations with less healthcare access, lower health literacy, or greater competing demands on their time.

Recruitment Challenges Across Diverse Populations

What Participating in a Dementia Prevention Trial Actually Involves

If you’ve seen recruitment for dementia prevention trials, you might wonder what participation actually entails. Most trials require multiple clinic visits for cognitive testing, physical assessments, blood work, and brain imaging in some cases. Participants complete questionnaires about their health history, cognitive complaints, and lifestyle. Then, if randomly assigned to the intervention group, they receive structured support for the intervention components—which might mean weekly gym sessions, dietitian visits, computerized cognitive training, and regular clinic visits to monitor progress. This typically continues for 12-24 months.

Participation is usually free for enrolled participants, and some trials offer small incentives or compensation for time. The time commitment is substantial. For working people with families, fitting in regular exercise, dietary changes, cognitive training, and clinic visits requires real dedication. This is one reason recruitment can be challenging—the people most at risk for dementia (those already showing cognitive concerns) are sometimes least able to commit the time. Conversely, relatively healthy people who can easily accommodate the intervention lifestyle are exactly the people who might not develop dementia anyway.

What the Future Holds for Dementia Prevention Research

The global coordination of dementia prevention trials is still relatively young. The 13 completed FINGER-based trials and 15 ongoing trials represent an unprecedented attempt to validate and refine the approach across diverse populations. If the results continue to support the efficacy of multidomain interventions, the next challenge will be implementation—how to make these interventions available to millions of people who can’t access specialized research programs.

This might mean adapting the approach for delivery through primary care clinics, community centers, or digital platforms that don’t require the intensive in-person support provided in research trials. The findings could also shift how healthcare systems approach brain health. Instead of waiting for people to develop cognitive symptoms and then offering limited options, preventive approaches could become standard in midlife or early aging. However, this requires shifting attitudes about who benefits from prevention and ensuring that prevention programs reach people at actual risk, not just the affluent and highly educated.

Conclusion

While there isn’t a single trial with exactly 25,000 participants across 8 countries, the coordinated global effort through the World-Wide FINGERS Network represents an unprecedented commitment to proving that lifestyle interventions can prevent dementia. The original Finnish FINGER trial demonstrated that multidomain approaches—combining exercise, nutrition, cognitive training, and vascular risk management—can improve cognitive function. Now, trials across 70+ countries are testing whether these benefits hold across diverse populations and healthcare systems.

The implications are significant: if lifestyle interventions can prevent or delay dementia, it offers hope for millions of people at risk. If you’re concerned about cognitive health or have a family history of dementia, clinical trials offer both the chance to contribute to this research and to receive structured interventions that show promise. You can explore active trials through ClinicalTrials.gov, the Alzheimer’s Association TrialMatch, or Alzheimer’s Disease International to find studies recruiting in your region.